INTRODUCTION
In the last 10 years there has been an increase in the number of cases of tuberculosis in many countries of the world including U.S.A with a significant increase among certain population groups. Factors contributing to this increase are HIV infection, homelessness, poverty, deterioration in the public health services and immigration from countries with high incidence of tuberculosis (1) . Concurrent with the recent increase in the incidence of tuberculosis there has been a steady increase in drug resistance in M. tuberculosis with serious consequences in hospitals (2) and prisons especially in individuals infected with HIV(3) Important advances in the understanding of the molecular basis of drug resistance in M. tuberculosis have been achieved (4) , particularly with regard to the association of Author for correspondence: Dr. Manju Sharma, Associate Professor, 3/7J, Medical Enclave, Rohtak-124001 (India) Tel: 91-1262-44878, E-mail: m.nitya@mailcity.com & manju_sh@hotmail.com resistance to isoniazid, deletion (5) and mutation (6) in the katG geneo Mutations also have been described in other genes such as rpoB gene encoding for the f~ subunit of RN~, polymerase associated with rifampicin resistance (7) ; rrs encoding for 16 S RNA gene and gene S 12 encoding for ribosomal protein associated with streptomycin resistance (8) . Understanding of the molecular basis of drug resistance has contributed to the development of rapid diagnostic tests. A single strand (SS) DNA molecule reassociatesitself forming hairpin structure with characteristic secondary structure depending on the nucleotide sequence. The presence of a mutation leads to the formation of a different secondary structure that can be detected by the rate of mobility in a gel, which is the basis of SSCP analysis (9) . Mutations in rifampicin-resistant M.tubercu/osis isolates have been detected using a line probe assay (10) . Recently cleavase analysis for detecting mutations in M. tuberculosis KatG genes has been described (11) .In the present study we applied SSCP and CFLP analysis to the rapid identification of genes encoding resistance to INH, RIF and STR.
MATERIALS AND METHODS
Twenty isolates of drug resistant M.tuberculosis were obtained from the British Columbia Centre for Disease Control (BCCDC). All samples were tested for drug-susceptibility using the radiometric method BACTEC 460 (Becton Dickinson, Mississauga, Ontario) with isoniazid concentrations of 0.1 mg/ ml, rifampicin 2mg/ml and streptomycin 2mg/ml. Three large full loops of mycobacteria culture grown in solid Middlebrook media were harvested and resuspended in 500 Ill TE buffer (10 mM Tris Hcl, 1 mM EDTA, pH 8.0). The samples were heat inactivated for 30 min at 95 ~ An equal volume of chloroform was added, and the samples were mixed by rotation for 20 min. The tubes were placed in an ultrasonic cleanser (Bransonic, Branson Cleaning Equipment, Shelton CT) at 65 ~ for 20 min. The samples were centrifuged in a microcentrifuge for 1 min. The aqueous phase was recovered and the DNA concentration was determined using a mini fluorometer TKO 100 (Hoefer scientific Instruments, San francisco CA).
OligonucleoUde synthesis
Oligonucleotide primers katG 1 5'-GCCCGAGCAACACCC-3' and katG 2 5'-ATGTCCCGCGTCAGG-3' from the katG gene from M.tuberculosis with GenBank accession number S42739; primers rif 139 5'-ATCCGGCCGGTGGTCGC-3' and nf296 5'-CGGGTGCACGTCGCGGA-3' for rpoB gene (~ subunit of RNA polymerase) with GenBank accession number L05910 and primers m 16S309 5'-GGCAGCAGTGGGGAATA-3' and m16S658 5'-ACCGGTGTTCCTCCTGA-3' from the rrs gene that codes for 16S RNA with GenBank accession number X52917 were selected and synthesized at UBC Biotechnology Laboratory. Sequencing primers were synthesized and labeled at the 5' end with fluorescein amidite (FluorePrime, Pharmacia LKB Biotechnology Uppsala, Sweden). Primers were purified by HPLC in a Pep S reverse phase column (Pharmacia).
DNA amplification
Polymerase chain reaction (PCR) was done in 25 Ill volume reaction mixture containing (final concentrations) 1.25 mM HgCI2,25 mM KCI, 10 mM Tns-HCI pH 8.3, 0.01% gelatine, 20 mM of each of the four d NTPs, 20 mM of each of the 2 primers, 3 ng of template DNA, and 1 unit of Taq DNA polymerase (BRL), covered with 15 pl mineral oil. Amplification was done for 35 cycles with denaturing at 94 ~ for 1.5 min, annealing at 68 ~ for katG, 70~ for rpoB and 57 ~ for rrs and extension at 72~ for 1 min.
Gel electrophoresis
Ten percent of the PCR reaction was analysed by electrophoresis in a 2 % agarose gel using a 100 bp DNA marker ladder (Pharmacia). Gels were stained with ethidium bromide and photogragphed under a 300 nm UV transilluminator (Fotodyne, New Berlin, Wisconsin). Positive amplification was identified by detection of 237 bp fragment for katG, 174 bp for rpoB and 366 bp for 16S RNA rrs gene.
DNA sequencing
PCR products were purified in a QIA quickspin PCR purification column (QIAGEN, Chatsworth, CA). Both strands of the PCR product were sequenced using fluorescein labeled primers and cycle sequencing reactions (Autocycle Sequencing Kit, Pharmacia) in the presence of Thermus thermophilus DNA polymerase in the Perkin-Elmer Cetus DNA Thermal cycler. The cycles were : 94 o C for 1 min, annealing at 68 o C for katG, 70 o C for rpoB and 57 o C for rrs for 1 min, extension at 72 o C for 1.5 min for 17 cycles and then 13 cycles of denaturing at 94 o C for 1 min and extension at 72 0 C for 1.5 min. The sequencing reactions were analysed in an Automatic Laser Fluorescent (ALF) DNA sequencer from Pharmacia (Uppsala, Sweden).
Single strand conformation polymorphism
PCR amplification of the isolates was performed as above except that 6.26 ~M of fluorescein-11-dUTP (FdUTP, Pharmacia) was added to the PCR reaction. The PCR products were purified in a QIA quick-spin PCR purification column. The purified PCR products were denatured at 95 o C for 5 minutes prior to analysis on a 6 % acrylamide, 7 M urea gel, using a 50-500 bp fluorescein labeled DNA ladder marker in the ALF DNA sequencer (Pharmacia). A fluorogram was obtained at 40 o C.
Cleavase Fragment Length Polymorphism (CFLP)
CFLP reactions were prepared using the CFLP Evaluation Kit Polymorphism Detection System (Third Wave Technologies, Madison Wl). PCR reactions were made in the presence of 6.251JM FdUTP. The PCR products were purified in a QIA quick spin column and then were treated with 50 Units of Exonuclease I (USB Cleveland 
Computer analysis
Multiple sequence alignments were made with the program Clustal V ; a phylogenetic tree was constructed using the DeSoete Tree fit; secondary structure of the SS DNA was studied with the program M FOLD-RNA secondary prediction; all these programs were implemented in genetic Data Environment. The fluorograms were analysed with the fragment Manager software (Pharmacia). differentiate between two sreptomycin resistant isolates and a sensitive one. The sensitive isolate showed a single peak at 366 bp and the resistant had two peaks with 9 bases difference.
RESULTS
DNA sequence of the 174-bp amplified portion of the rpoB gene showed a mutation in base 95 (A to G) corresponding to amino acid number 526, (histidine to arginine) in all 4 resistant isolates, one of these isolates (r 2424) also had a mutation in base 110 (C to T), corresponding to amino acid 531 (serine to leucine). The DNA sequence of the INHresistant cases showed mutations distributed at random in all 14 cases with 1 to 5 base mismatches. Alterations included point mutations, deletions and insertions up to two bases. In four isolates there was a mutation in amino acid 65 (alanine to serine). The phylogenetic analysis showed a cluster of six isolates with small differences from the INH-sensitive isolates; there were two, samples with more mutations and were located distant to the reference isolate (data not shown).
CFLP analysis showed a different pattern among rifampicin, INH and streptomycin-sensitive and resistant isolates (Figure 2 ). The rpoB sequences of rifampicin-sensitive and resistant isolates have very similar secondary structures with some differences at the level of the position of the mutations present in the rifampicin-resistant isolate~s (Figure 3) . Cleavase cuts the single stranded DNA molecule at the beginning or at the end of the hairpin structure. Inside a hairpin, Cleavase cuts when there is no base pairing, or if there is a mismatch (G-T). We found that Cleavase recognised a single mutation Iocalised at position 95 of our sequence (amino acid 526 of the whole sequence) in isolates r2418, r2422 and r2430. Cleavase also recognised the location of two mutations in isolate r2424 associated with rifampicin resistance. These mutations were located in position 95 and 110 of our sequence corresponding to amino acid 526 and 531 of the whole sequence (Figures 2-3) .The secondary structure of the katG gene sequence from IN H-resistant isolates showed great variability when compared with pattem from the I NH-sensitive isolates (data not shown); this variability correlated with the difference in patterns observed in the CFLP analysis (Figure 2 ). Streptomycin-resistant isolates showed a band in position 166bp that correlated with a mutation A to C in position 513 of the original description (8)
DISCUSSION
Important advances in the understanding of molecular basis of drug resistance in M.tuberculosis have been achieved (4, 12) leading to the identification of 12 genes associated with drug resistance in this organism (13) . Thus molecular basis of drug resistance has contributed to the development of rapid diagnostic tests. Nucleic acid assays for rapid susceptibility testing are based on the detection of differences between the genetic material of a resistant and a susceptible strain. It has been observed that SSCP is simple, accurate and suitable for analysis of a large number of samples. CFLP has similar characteristics and is also able to provide information on the location of sing!e base mutation. We have compared the difference by amplifying portions of rpoB, katG and rrs genes ( both sensitive and resistant) by DNA sequence, SSCP and CFLP. Each of these procedures gave specific information to make distinction. SSCP is a procedure based on the detection of changes in the rate of mobility of the SS DNA due to the presence of a single base mutation that produced conformational changes in the molecule. In our study PCR-SSCP of all the resistant RIF and INH isolates showed an extra peak at the level of 75-bp and 85-bp respectively. While, STR resistant isolate showed double peak with a difference of 9 bases.Isolates with abnormal SSCP could be the subject of further analysis including DNA sequencing and CFLP. CFLP analysis is based on the use of the enzyme Cleavase I that recognises and cleaves the SS DNA molecule at the level of a conformational change or the presence of mutations. The method is highly sensitive in that it is able to identify a single base mutation and generate series of DNA fragments with a characteristic pattern for the mutated (resistant) and non-mutated (sensitive) organism.. Analysis of CFLP certainly looks littlle more complicated than SSCP ; however, it may yield more information about the resistance gene. While the DNA sequencing is highly accurate method for detection of mutations associated with drug resistance in tuberculosis but is more expensive and requires special equipment and personnel. Thus SSCP and CFLP are simple and sensitive methods, suitable for analysis of large number of samples and the results are available in less than 72 hours.
